KBC Group NV
- SEC CIK
- 0001411133
- Latest filing
- Aug 5, 2026
VKTX holding history
Viking Therapeutics, Inc. in every 13F filed by KBC Group NV, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VKTX overviewAll 13F holders of VKTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,960
- Value
- $154.0K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,960 | $154.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 3,960 | $129.0K | <0.1% | +1,030+35.2% | Added | Holders |
| Q4 2025 | 2,930 | $103.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 2,930 | $77.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 2,930 | $78.0K | <0.1% | −1,354−31.6% | Reduced | Holders |
| Q1 2025 | 4,284 | $103.0K | <0.1% | +30+0.7% | Added | Holders |
| Q4 2024 | 4,254 | $171.0K | <0.1% | +1,257+41.9% | Added | Holders |
| Q3 2024 | 2,997 | $190.0K | <0.1% | +473+18.7% | Added | Holders |
| Q2 2024 | 2,524 | $134.0K | <0.1% | +736+41.2% | Added | Holders |
| Q1 2024 | 1,788 | $147.0K | <0.1% | +1,788 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −1,445−100.0% | Sold out | Holders |
| Q3 2023 | 1,445 | $16.0K | <0.1% | +1,445 | New | Holders |